Secondary prevention of cervical cancer part 1: screening for cervical cancer and its precursors.
Discussion of screening for cervical cancer and it precursors, management of abnormal cervical cancer screening test, and evidence-based management of women with cervical intraepithelial neoplasia.
*Magee-Womens Hospital of the UPMC System, University of Pittsburgh, Pittsburgh, Pennsylvania †Washington University in St. Louis, St Louis, Missouri ‡Southern California Permanente Medical Group, Department of Obstetrics and Gynecology, Kaiser Permanente, Anhaheim, and Department of Obstetrics and Gynecology, University of California School of Medicine, Irvine, California.
Michelle
M
Boisen
Justin T
JT
Diedrich
Neal M
NM
Lonky
Richard
R
Guido
D001331:Automation; D005260:Female; D006801:Humans; D007118:Immunoassay / Q000379:methods; D008403:Mass Screening / Q000379:methods* / Q000592:standards*; D016133:Polymerase Chain Reaction; D017410:Practice Guidelines as Topic; D055502:Secondary Prevention; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis / Q000517:prevention & control*; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000517:prevention & control*; D014626:Vaginal Smears